The use of mechanical circulatory support for patients presenting with cardiogenic shock is
rapidly increasing. Currently, there is only limited and conflicting evidence available …

Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …

Acute myocardial infarction (AMI) continues as the main cause of morbidity and mortality
worldwide. Interestingly, emerging evidence highlights the role of gut microbiota in …

Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the
most common cause, and a percutaneous microaxial ventricular assist device (Impella …

Background The in-hospital mortality of patients with ST-segment elevation myocardial
infarction (STEMI) increases to more than 50% following a cardiogenic shock (CS) event …

Systemic sarcoidosis can lead to heart failure, conduction abnormalities and ventricular
arrhythmias although data on concomitant valvular heart disease (VHD) is limited. We …

Background There is a lack of data on age‐stratified sex differences in the incidence,
treatment, and outcomes of cardiogenic shock (CS). We sought to study these differences …

Background Heart failure (HF) imparts a significant clinical and economic burden on the
health system in the United States. Methods and Results We used the National Inpatient …

OBJECTIVES Patients in cardiogenic shock supported with venoarterial extracorporeal
membrane oxygenation (VA-ECMO) may experience severe complications from reduced left …

Background There is limited real-world data highlighting recent temporal in-hospital
morbidity and mortality trends for cases of acute myocardial infarction complicated by …